Breaking Ukraine Launches Major Drone Offensive; Russian Strike Hits Kharkiv Village UK Vows No Intimidation After Russian Embassy Warning Over Ukraine Drone Shipments Trump Reportedly Threatened to Bomb Oman Over Iran Deal Concerns Justice Department Watchdog Reviews DEA Tactic Allowing Fentanyl to Reach Streets Supreme Court Rejects Trump’s Latest Bid to Overturn $5 Million E. Jean Carroll Verdict

Tuesday August 18, 2026

Reporter

BridgeBio Pharma, Inc.

6Articles Published

4Communities Covered

Published Articles

Press Release

BridgeBio Pharma Announces Pricing of Oversubscribed Secondary Offering that Diversifies its Institutional Shareholder Base

Aug 14

Press Release

BridgeBio Pharma Announces Launch of Secondary Offering of Common Stock on Behalf of an Existing Shareholder

Aug 13

Press Release

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Aug 11

Press Release

BridgeBio Reports Second Quarter 2026 Financial Results and Corporate Updates

Aug 10

Press Release

BridgeBio to Report Second Quarter 2026 Financial Results and Commercial Updates on August 10, 2026 at 4:30 pm ET

Aug 3

Press Release

BridgeBio Announces FDA Acceptance of NDA for Encaleret for ADH1

Jul 22